Improving our understanding of the underlying mechanism behind endocrine resistance and to identify biomarkers for an individualized approach to cancer therapy.
Organotypic model for breast cancer therapy prediction. We have successfully established our unselected ex vivo 3D cell culture (WTC) model.
The human epidermal growth factor receptor 2 (HER2) is overexpressed or gene amplified in about 15 % of breast cancers and is associated with aggressive tumors
We use established image analysis softwares to improve biomarker assessment in routine pathology. We also develop in-house deep-learning based models for next generation image analysis together with the Rantalainen lab.
Medical doctor currently a resident in surgical pathology at Karolinska University Laboratory
A medical doctor currently a resident in surgical pathology at Karolinska University Laboratory
Physician and postdoc researcher with experience in digital pathology.
Medical doctor and currently PhD student focusing on the endocrine treatment resistance mechanism
focus on establishing various ex vivo models for breast cancer treatment study, cancer stem cells, and tumor heterogeneity
focus on establishing and utilizing cancer patient derived ex vivo models to assist precision oncology and novel drug development
Electronic and Computer Engineer by training with experience in Bioinformatics
Coordinator and assistant of all the research projects within the group.
Copyright by Hartman Lab. All rights reserved.